| Application no. and date | 01911078.2 (espacenet) (Federated) (European Patent Register), 20010221 | | Patent/reg. no. and date | DK/EP 1292303, 20040512 | | Publication date | 20030319 | | Priority no. and date | | | EP pub. no. and date |
EP 1292303 20030319 | | Effective date | | | Applicant/owner | TEVA PHARMACEUTICAL INDUSTRIES LTD., 5 Basel Street,
P.O. Box 3190
49131 Petah Tiqva, IL | | Applicant ref. no. | 119207 | | Inventor | LEIBOVICI, Minutza, 3/1 Gershon Shatz St.
Netanya, IL,
TENENGAUZER, Ruth, 9/4 Ben Gamla Street
Hod HaSharon, IL,
ARONHIME, Judith, 9/7 Hava Lutzky Street
44244 Rehovot, IL,
KORDOVA, Marco, 78/14 Rothchild
Kfar Saba, IL,
KOPEL, Mira, P.O. Box 1298
Pardess Hanna, IL | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61P 7/10 (2006.01) | | Title | Stabil farmaceutisk formulering omfattende torsemidmodifikation II | | Int. application no. | US2001005577 | | Int. publication no. | WO2002067935 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
